CI Investments Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Sell |
4,251
-3,487
| -45% | -$1.83M | 0.01% | 350 |
|
|
2025
Q1 | $4.91M | Buy |
7,738
+2,508
| +48% | +$1.59M | 0.02% | 301 |
|
|
2024
Q4 | $3.73M | Sell |
5,230
-1,910
| -27% | -$1.36M | 0.01% | 319 |
|
|
2024
Q3 | $7.51M | Buy |
7,140
+1,142
| +19% | +$1.2M | 0.03% | 266 |
|
|
2024
Q2 | $6.3M | Buy |
5,998
+2,263
| +61% | +$2.38M | 0.02% | 257 |
|
|
2024
Q1 | $3.6M | Buy |
3,735
+1,334
| +56% | +$1.28M | 0.01% | 306 |
|
|
2023
Q4 | $2.11M | Sell |
2,401
-284
| -11% | -$249K | 0.01% | 325 |
|
|
2023
Q3 | $2.21M | Sell |
2,685
-301
| -10% | -$248K | 0.01% | 317 |
|
|
2023
Q2 | $2.15M | Buy |
2,986
+1,075
| +56% | +$773K | 0.01% | 324 |
|
|
2023
Q1 | $1.57M | Buy |
1,911
+729
| +62% | +$599K | 0.01% | 345 |
|
|
2022
Q4 | $853K | Buy |
1,182
+218
| +23% | +$157K | ﹤0.01% | 384 |
|
|
2022
Q3 | $664K | Buy |
964
+100
| +12% | +$68.9K | ﹤0.01% | 400 |
|
|
2022
Q2 | $511K | Sell |
864
-356
| -29% | -$211K | ﹤0.01% | 469 |
|
|
2022
Q1 | $852K | Buy |
1,220
+33
| +3% | +$23K | ﹤0.01% | 455 |
|
|
2021
Q4 | $750K | Buy |
1,187
+83
| +8% | +$52.4K | ﹤0.01% | 513 |
|
|
2021
Q3 | $668K | Buy |
1,104
+386
| +54% | +$234K | ﹤0.01% | 521 |
|
|
2021
Q2 | $401K | Sell |
718
-22
| -3% | -$12.3K | ﹤0.01% | 648 |
|
|
2021
Q1 | $350K | Buy |
740
+44
| +6% | +$20.8K | ﹤0.01% | 597 |
|
|
2020
Q4 | $336K | Sell |
696
-44
| -6% | -$21.2K | ﹤0.01% | 600 |
|
|
2020
Q3 | $414K | Buy |
740
+282
| +62% | +$158K | ﹤0.01% | 444 |
|
|
2020
Q2 | $286K | Buy |
+458
| New | +$286K | ﹤0.01% | 476 |
|